nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—adrenal cortex—polycystic ovary syndrome	0.0297	0.107	CbGeAlD
Ingenol Mebutate—PRKCD—endometrium—polycystic ovary syndrome	0.0265	0.0958	CbGeAlD
Ingenol Mebutate—PRKCD—pituitary gland—polycystic ovary syndrome	0.024	0.0867	CbGeAlD
Ingenol Mebutate—PRKCD—adipose tissue—polycystic ovary syndrome	0.0239	0.0863	CbGeAlD
Ingenol Mebutate—PRKCD—adrenal gland—polycystic ovary syndrome	0.0214	0.0774	CbGeAlD
Ingenol Mebutate—PRKCD—female gonad—polycystic ovary syndrome	0.02	0.0722	CbGeAlD
Ingenol Mebutate—PRKCA—embryo—polycystic ovary syndrome	0.02	0.0721	CbGeAlD
Ingenol Mebutate—PRKCD—vagina—polycystic ovary syndrome	0.0199	0.0717	CbGeAlD
Ingenol Mebutate—PRKCD—endocrine gland—polycystic ovary syndrome	0.0186	0.0671	CbGeAlD
Ingenol Mebutate—PRKCA—uterus—polycystic ovary syndrome	0.0135	0.0486	CbGeAlD
Ingenol Mebutate—PRKCA—pituitary gland—polycystic ovary syndrome	0.0132	0.0478	CbGeAlD
Ingenol Mebutate—PRKCA—adipose tissue—polycystic ovary syndrome	0.0132	0.0476	CbGeAlD
Ingenol Mebutate—PRKCA—adrenal gland—polycystic ovary syndrome	0.0118	0.0427	CbGeAlD
Ingenol Mebutate—PRKCA—female gonad—polycystic ovary syndrome	0.011	0.0398	CbGeAlD
Ingenol Mebutate—PRKCA—endocrine gland—polycystic ovary syndrome	0.0102	0.037	CbGeAlD
Ingenol Mebutate—PRKCA—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00024	0.000331	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PNPLA2—polycystic ovary syndrome	0.000238	0.00033	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000238	0.000329	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000238	0.000329	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ATF1—polycystic ovary syndrome	0.000237	0.000328	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000237	0.000327	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IGF1—polycystic ovary syndrome	0.000236	0.000326	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT2—polycystic ovary syndrome	0.000236	0.000326	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ATF1—polycystic ovary syndrome	0.000234	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—RACGAP1—polycystic ovary syndrome	0.000234	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000233	0.000322	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000231	0.00032	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IRS1—polycystic ovary syndrome	0.000231	0.000319	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00023	0.000319	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00023	0.000318	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HMMR—polycystic ovary syndrome	0.00023	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IRS1—polycystic ovary syndrome	0.000229	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SCT—polycystic ovary syndrome	0.000228	0.000315	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SRD5A1—polycystic ovary syndrome	0.000226	0.000313	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000225	0.000311	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000224	0.000309	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000222	0.000307	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00022	0.000304	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00022	0.000304	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—TAB1—polycystic ovary syndrome	0.000219	0.000303	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	0.000219	0.000302	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000218	0.000301	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PRL—polycystic ovary syndrome	0.000217	0.0003	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—SERPINE1—polycystic ovary syndrome	0.000216	0.000299	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—TAB1—polycystic ovary syndrome	0.000216	0.000298	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—STAR—polycystic ovary syndrome	0.000216	0.000298	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000214	0.000296	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TCF7L2—polycystic ovary syndrome	0.000214	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT2—polycystic ovary syndrome	0.000214	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000212	0.000293	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT2—polycystic ovary syndrome	0.000212	0.000293	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—IL6—polycystic ovary syndrome	0.000212	0.000293	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000212	0.000293	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000211	0.000292	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SLC2A4—polycystic ovary syndrome	0.00021	0.00029	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—GNAS—polycystic ovary syndrome	0.000209	0.000289	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000209	0.000289	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AR—polycystic ovary syndrome	0.000207	0.000286	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000205	0.000284	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PRL—polycystic ovary syndrome	0.0002	0.000277	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—IL6—polycystic ovary syndrome	0.0002	0.000277	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000199	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000198	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT2—polycystic ovary syndrome	0.000197	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000196	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000195	0.00027	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000194	0.000268	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000193	0.000267	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HMMR—polycystic ovary syndrome	0.000192	0.000266	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGF18—polycystic ovary syndrome	0.00019	0.000263	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000189	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKR1C1—polycystic ovary syndrome	0.000189	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—INSR—polycystic ovary syndrome	0.000187	0.000258	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—BCL2—polycystic ovary syndrome	0.000185	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HSD3B1—polycystic ovary syndrome	0.000183	0.000254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL18—polycystic ovary syndrome	0.000182	0.000252	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NCOR1—polycystic ovary syndrome	0.000181	0.00025	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NRG1—polycystic ovary syndrome	0.000178	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000177	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000176	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NRG1—polycystic ovary syndrome	0.000176	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGF18—polycystic ovary syndrome	0.000175	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—YAP1—polycystic ovary syndrome	0.000175	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000175	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RBP4—polycystic ovary syndrome	0.000174	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—GAB1—polycystic ovary syndrome	0.000173	0.00024	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PGR—polycystic ovary syndrome	0.000173	0.000239	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000172	0.000238	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000172	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL6—polycystic ovary syndrome	0.000171	0.000236	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—IL6—polycystic ovary syndrome	0.00017	0.000235	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—IL6—polycystic ovary syndrome	0.000168	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NCOR1—polycystic ovary syndrome	0.000168	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NR3C1—polycystic ovary syndrome	0.000167	0.000231	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—LHB—polycystic ovary syndrome	0.000167	0.000231	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NRG1—polycystic ovary syndrome	0.000165	0.000228	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000163	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—IL6—polycystic ovary syndrome	0.000163	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000161	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000161	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000161	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—GAB1—polycystic ovary syndrome	0.00016	0.000221	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000158	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CAMK2D—polycystic ovary syndrome	0.000158	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IL6—polycystic ovary syndrome	0.000158	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000156	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NAMPT—polycystic ovary syndrome	0.000156	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TNRC6B—polycystic ovary syndrome	0.000155	0.000215	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000155	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000154	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—VEGFA—polycystic ovary syndrome	0.000154	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000153	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—IL6—polycystic ovary syndrome	0.000153	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IRS2—polycystic ovary syndrome	0.000153	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CRP—polycystic ovary syndrome	0.000153	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PGR—polycystic ovary syndrome	0.000153	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—IL6—polycystic ovary syndrome	0.000152	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—IL6—polycystic ovary syndrome	0.000151	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000151	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IRS2—polycystic ovary syndrome	0.000151	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CRP—polycystic ovary syndrome	0.000151	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—IL6—polycystic ovary syndrome	0.000151	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00015	0.000207	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000149	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MTHFR—polycystic ovary syndrome	0.000148	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000147	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000146	0.000201	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKR1C3—polycystic ovary syndrome	0.000146	0.000201	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FST—polycystic ovary syndrome	0.000143	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TNRC6B—polycystic ovary syndrome	0.000143	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000142	0.000197	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—IL6—polycystic ovary syndrome	0.000142	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—IL6—polycystic ovary syndrome	0.000142	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000142	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000142	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IRS2—polycystic ovary syndrome	0.000141	0.000195	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—RRM2—polycystic ovary syndrome	0.000141	0.000195	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000141	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—IL6—polycystic ovary syndrome	0.00014	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PRL—polycystic ovary syndrome	0.00014	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LHB—polycystic ovary syndrome	0.00014	0.000193	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—IL6—polycystic ovary syndrome	0.000139	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—IL6—polycystic ovary syndrome	0.000139	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000137	0.000189	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ATF1—polycystic ovary syndrome	0.000136	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—YAP1—polycystic ovary syndrome	0.000136	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IGF1—polycystic ovary syndrome	0.000135	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT2—polycystic ovary syndrome	0.000135	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000135	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IRS1—polycystic ovary syndrome	0.000133	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000133	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000132	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000132	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IRS1—polycystic ovary syndrome	0.000132	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SCT—polycystic ovary syndrome	0.000131	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NAMPT—polycystic ovary syndrome	0.000131	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PPARG—polycystic ovary syndrome	0.00013	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000129	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000129	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000129	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TAB1—polycystic ovary syndrome	0.000126	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	0.000125	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000125	0.000173	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PRL—polycystic ovary syndrome	0.000125	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT2—polycystic ovary syndrome	0.000123	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000123	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IRS1—polycystic ovary syndrome	0.000123	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000123	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TCF7L2—polycystic ovary syndrome	0.000123	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000122	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000122	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT2—polycystic ovary syndrome	0.000122	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000121	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SLC2A4—polycystic ovary syndrome	0.000121	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP17A1—polycystic ovary syndrome	0.00012	0.000166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00012	0.000166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AR—polycystic ovary syndrome	0.000119	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—INS—polycystic ovary syndrome	0.000118	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000118	0.000162	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000117	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000115	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PRL—polycystic ovary syndrome	0.000115	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT2—polycystic ovary syndrome	0.000114	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000114	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000112	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SERPINE1—polycystic ovary syndrome	0.000108	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—BCL2—polycystic ovary syndrome	0.000108	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—INSR—polycystic ovary syndrome	0.000107	0.000148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—BCL2—polycystic ovary syndrome	0.000106	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL18—polycystic ovary syndrome	0.000105	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NCOR1—polycystic ovary syndrome	0.000104	0.000144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TH—polycystic ovary syndrome	0.000104	0.000144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NRG1—polycystic ovary syndrome	0.000102	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000102	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000101	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.0001	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PGR—polycystic ovary syndrome	9.93e-05	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IRS2—polycystic ovary syndrome	9.88e-05	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—LEP—polycystic ovary syndrome	9.67e-05	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—polycystic ovary syndrome	9.65e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NCOR1—polycystic ovary syndrome	9.64e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NR3C1—polycystic ovary syndrome	9.61e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—polycystic ovary syndrome	9.59e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP19A1—polycystic ovary syndrome	9.49e-05	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NRG1—polycystic ovary syndrome	9.46e-05	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GHRL—polycystic ovary syndrome	9.23e-05	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PLAT—polycystic ovary syndrome	9.23e-05	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.89e-05	0.000123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—polycystic ovary syndrome	8.84e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ATF1—polycystic ovary syndrome	8.81e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CRP—polycystic ovary syndrome	8.78e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IRS2—polycystic ovary syndrome	8.78e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IRS1—polycystic ovary syndrome	8.63e-05	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.59e-05	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.55e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTHFR—polycystic ovary syndrome	8.52e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNAS—polycystic ovary syndrome	8.47e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—POMC—polycystic ovary syndrome	8.31e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—INS—polycystic ovary syndrome	8.26e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NGFR—polycystic ovary syndrome	8.13e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IRS2—polycystic ovary syndrome	8.1e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—POMC—polycystic ovary syndrome	8.08e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NCOR1—polycystic ovary syndrome	8.07e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRL—polycystic ovary syndrome	8.06e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1—polycystic ovary syndrome	7.99e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT2—polycystic ovary syndrome	7.98e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.76e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IRS1—polycystic ovary syndrome	7.66e-05	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP1A1—polycystic ovary syndrome	7.65e-05	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.64e-05	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.59e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—polycystic ovary syndrome	7.44e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTHFR—polycystic ovary syndrome	7.13e-05	9.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT2—polycystic ovary syndrome	7.09e-05	9.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNAS—polycystic ovary syndrome	7.09e-05	9.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IRS1—polycystic ovary syndrome	7.08e-05	9.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—INS—polycystic ovary syndrome	6.78e-05	9.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.75e-05	9.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SERPINE1—polycystic ovary syndrome	6.7e-05	9.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NRG1—polycystic ovary syndrome	6.63e-05	9.16e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT2—polycystic ovary syndrome	6.55e-05	9.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SERPINE1—polycystic ovary syndrome	6.22e-05	8.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—BCL2—polycystic ovary syndrome	6.2e-05	8.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—polycystic ovary syndrome	6.11e-05	8.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—polycystic ovary syndrome	5.79e-05	8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—POMC—polycystic ovary syndrome	5.71e-05	7.89e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IRS2—polycystic ovary syndrome	5.68e-05	7.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—INS—polycystic ovary syndrome	5.67e-05	7.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—polycystic ovary syndrome	5.58e-05	7.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LEP—polycystic ovary syndrome	5.55e-05	7.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—polycystic ovary syndrome	5.51e-05	7.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.22e-05	7.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—polycystic ovary syndrome	5.15e-05	7.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IRS1—polycystic ovary syndrome	4.95e-05	6.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—POMC—polycystic ovary syndrome	4.77e-05	6.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—INS—polycystic ovary syndrome	4.74e-05	6.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1—polycystic ovary syndrome	4.59e-05	6.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT2—polycystic ovary syndrome	4.59e-05	6.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.36e-05	6.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—polycystic ovary syndrome	3.61e-05	4.99e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—polycystic ovary syndrome	3.51e-05	4.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—polycystic ovary syndrome	3.21e-05	4.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—polycystic ovary syndrome	3e-05	4.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—polycystic ovary syndrome	2.96e-05	4.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—polycystic ovary syndrome	2.07e-05	2.87e-05	CbGpPWpGaD
